ANTICANCER, INC.

ACTIGEN

chemical reagents for in vitro research laboratory use to modify gene expression;

ACTIGEN

pharmaceutical compositions for modifying gene expression useful in therapy of various diseases including cancer and aging;

ACTIGEN

cosmetic with biological activity for modifying gene expression;

ACTIGENASE

pharmaceutical compositions for modifying gene expression;

AIDSASE

pharmaceutical compositions for treating AIDS;AIDS-ASE;

ALOSOME

pharmaceutical compositions for treating hair loss;

ANAGENOSOME

pharmaceutical compositions for treating hair growth;

ANAGENOSOME

cosmetic with biological activity for treating hair growth;

ANGIOBRITE

ANGIOGENESIS BRIGHT;biochemical reagents for scientific or medical research use for the detection of angiogenesis in tissues;

ANGIOMOUSE

biological assay system, consisting primarily of reagents for measuring the biological response of test agents, for scientific or medical research;

APOGEN

chemical reagents for inducing apoptosis;

APOGEN

pharmaceutical compositions for inducing apoptosis;

APOPTASE

pharmaceutical compositions for inducing apoptosis;

AUTOHDRA

Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids;AUTO HISTOCULTURE DRUG RESPONSE ASSAY;

CARDIOASE

chemical reagents for in vitro diagnosis of cardiovascular disease;

CARDIOASE

pharmaceutical compositions for treating cardiovascular disease;

CARDIOTECH

pharmaceutical compositions for treating cardiovascular disease;

CARDIOTECH

chemical reagents for in vitro diagnosis of cardiovascular disease;

CATAGENOSOME

pharmaceutical compositions for inducing hair loss;

CATAGENOSOME

hair preparation with biological activity for inducing hair loss;

COSMEPEUTIC

skin preparation with biological activity to improve skin quality;

COSMEPEUTIC

pharmaceutical with biological activity to improve hair or skin quality;

DEMETHYL

pharmaceutical compositions for in-vivo depletion of methionine in a patient;

DEMETHYL

reagents for scientific or medical research use for in-vitro diagnosis of methionine or methylation depletion;

DERMATEK

conducting biological assays to measure biological response of test agents;

DETECTASE

DETECT-ASE;chemical reagents for detection and/or diagnosis of diseases such as cancer, for scientific (or medical) research purposes;

FOLMOBILE

therapeutic compositions containing reagents for in vivo mobilization of folates;FOLATES MOBILE;

FOLMOBILE

chemical reagents for in vitro diagnosis of folate mobilization for medical diagnostic purposes;FOLATE MOBILIZATION;

GENEBRITE

pharmaceutical composition for treatment of cancer, and cardiovascular, neurological, dermatological, gastrointestinal and internal organ diseases;

GENECEUTICAL

therapeutic compositions containing nucleic acids for gene therapy;

GERONTASE

pharmaceutical compositions for treating the aging process;

GERONTEK

pharmaceutical compositions for treating the aging process;

GERONTEK

chemical reagents for in vitro diagnosis of the aging process;

HAP STEM CELLS

Stem cells for medical purposes;Stem cells for research or scientific purposes;

HAPS

Stem cells for medical purposes;Stem cells for research or scientific purposes;

HC TEST

chemical reagents for diagnosis of homocysteine or cardiovascular disease;

HDRA

conducting biological assays to measure biological response of test agents;

HOMOSTATIN

Pharmaceutical comopostion for elevated homocysteinemia;

HYASE

chemical reagents containing homocysteinase, for in vitro diagnosis of homocysteine in blood or urine for medical diagnostic purposes;HOMOCYSTEINE BASE;

HYASE

pharmaceutical compositions for in vivo reduction of homocysteine;HOMOCYSTEINE BASE;

HYCURE

pharmaceutical with biological activity to treat hyperhomocysteinemia;HYPERHOMOCYSTEINEMIA CURE;

HYTEST

chemical reagents for in vitro diagnosis of homocysteine in blood or urine for medical diagnostic purposes;HOMOCYSTEINE TEST;

LIPOGENOSOME

theapeutic compositions containing liposome reagents suitable for gene therapy;

LIPOPECIA

pharmaceutical for promoting hair growth;

LYMPHOTEK

pharmaceutical compositions for treating immunodeficiency disorders, including AIDS;

LYMPHOTEK

chemical reagents for in vitro diagnosis of immunodeficiency disorders, including AIDS;

MAMMARX

pharmaceutical compositions for treating breast cancer;

MAMMARX

chemical reagents for in vitro diagnosis of breast cancer;

MELASOME

pharmaceutical composition for treating hair color to control pigment;

MELASOME

hair dye with biological activity for treating hair color;

METAMOUSE

tumor assay system comprising biological reagents for detection of tumors, a mouse, and reagents for research use;

METAMOUSE

META MOUSE;conducting biological assays to measure biological response of test agents;

NEUROASE

pharmaceutical composition for treating neurological disorders;

OBESASE

pharmaceutical compositions for treating obesity;

ONCASE

therapeutic compositions containing reagents for in vivo anticancer use;

ONCASEPEG

therapeutic composition containing reagents for in vivo anticancer use;ON CASE PEG;

ONCOBRITE

ONCO BRIGHT;biochemical reagents for diagnosis of tumor cells for scientific or medical research use;

OPEN SCIENCE

Interactive online web journals featuring Scientific papers;Journals concerning Science;

PDOX

P DOX;Health care services for treating Cancer; Medical evaluation of Cancer;Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical testing services and information in the field of cancer research and disease classification; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of Cancer;

PETASE

medical reagents for in-vitro diagnosis by means of positron emmission tomography (PET) scanning;

PROSTATX

pharmaceutical compositions for treating prostate cancer;

PROSTATX

chemical reagents for in vitro diagnosis of prostrate cancer and benign prostatic hypertrophy;

TELOGENOSOME

hair preparation with biological activity for treating hair loss;

TELOGENOSOME

pharmaceutical compositions for treating hair loss;

TYROSOSOME

pharmaceutical composition for treating hair color to control pigment;

TYROSOSOME

hair preparation with biological activity for treating hair color;